12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Fluzone Quadrivalent: Phase III data

A blinded Phase III trial in >4,300 children ages 6 months to 8 years showed that antibody responses to intramuscular Fluzone Quadrivalent inactivated vaccine were non-inferior to both control vaccines - Fluzone trivalent inactivated 2010-2011 vaccine (containing type B strain of Victoria lineage) and an investigational trivalent inactivated...

Read the full 220 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >